image: Illustrated is a tumor-targeted dual-drug vehicle for a one-two knockout punch against aggressive cancer cell types, non-small cell lung cancer and triple negative breast cancer. This image relates to a paper that appeared in May 13, 2014, issue of Science Signaling, published by AAAS. The paper, by Stephen W. Morton at Massachusetts Institute of Technology in Cambridge, Mass., and colleagues was titled, "A Nanoparticle-Based Combination Chemotherapy Delivery System for Enhanced Tumor Killing by Dynamic Rewiring of Signaling Pathways." view more
Credit: [Credit: Stephen Morton]